摘要:
Compounds of the formula: ##STR1## wherein R.sub.1 is hydrogen, halogen, trifluoromethyl, alkyl, hydroxyl, alkyoxy, benzyloxy, alkanoyloxy, or benzoyloxy, or when R.sub.2 is hydroxyl or methoxy in the 4-position and R.sub.3 is hydrogen, R.sub.1 may also represent hydroxymethyl carbamoyl or alkoxycarbonyl,R.sub.2 is hydrogen, halogen, alkyl, hydroxyl, or alkoxy,R.sub.3 is hydrogen or alkyl,R.sub.4 is alkyl (in which case the compounds are (.+-.)-erythro) or when R.sub.3 represents hydrogen, R.sub.4 may also be hydrogen, and R.sub.5 is hydrogen, halogen, alkyl, alkoxy, or three methoxy groups in the 3-, 4- and 5-positions and pharmaceutically acceptable acid addition salts thereof, with the exclusion of compounds wherein:(a) one of R.sub.1 and R.sub.2 is in the 4-position and is hydroxyl, alkoxy or benzyloxy, the other is in the 3-position and is hydrogen, hydroxyl, alkoxy or benzyloxy, and R.sub.3 and R.sub.5 are hydrogen and wherein:(b) R.sub.1 is in the 4-position and is halogen, R.sub.4 is methyl and R.sub.2, R.sub.3 and R.sub.5 are hydrogen, are useful as medicaments.
摘要:
A pyrimidinedione derivative which is a compound of formula (I): ##STR1## in which: R1 denotes hydrogen, a halogen, a methyl group or a methoxy group,R2 denotes hydrogen, a C.sub.1 -C.sub.4 alkyl group or a benzyl group,n denotes 2, 3 or 4,X denotes a CH group or nitrogen, andR3 denotes hydrogen, a halogen or a methoxy group when X denotes a CH group, with the proviso that R3 denotes hydrogen when X denotes nitrogen,or a pharmacologically acceptable acid addition salt thereof.
摘要:
Compound of general formula I ##STR1## in which R is hydrogen, R.sub.1 is unsubstituted phenyl, 4-methoxy - 3,5-dimethylphenyl or phenyl substituted at one of the 2-, 3- or 4- positions by halogen, C.sub.1-4 alkyl, C.sub.1-4 alkoxy, hydroxy, benzyloxy, trifluoromethyl, cyano, nitro, amino, acetylamino, methylthio, methylsulphonyl or aminosulphonyl and R.sub.2 is unsubstituted phenyl, 2,4,6-trimethoxyphenyl or phenyl substituted at either the 3- or the 4- positions by fluorine, chlorine, methyl or methoxy, or an acid addition salt thereof.
摘要翻译:通式I的化合物其中R是氢,R 1是未取代的苯基,4-甲氧基-3,5-二甲基苯基或在2-,3-或4-位的一个被卤素取代的苯基, C 1-4烷基,C 1-4烷氧基,羟基,苄氧基,三氟甲基,氰基,硝基,氨基,乙酰氨基,甲硫基,甲基磺酰基或氨基磺酰基,R2是未取代的苯基,2,4,6-三甲氧基苯基或在3- 或氟,氯,甲基或甲氧基的4-位,或其酸加成盐。
摘要:
An electrophoretic method for purifying a nucleic acid sample is disclosed. The method generally comprises the steps of (1) providing a nucleic acid sample comprising a desired nucleic acid and one or more contaminants, (2) providing an electrophoresis matrix having a loading well and a recovery well formed therein, (3) placing the nucleic acid sample into the loading well, (4) performing a first electrophoresis comprising electrophoresing the nucleic acid sample for a first time effective to transport the desired nucleic acid out of the loading well and into the electrophoresis matrix; and (5) performing a second electrophoresis comprising electrophoresing the nucleic acid sample for a second time effective to transport the desired nucleic acid out of the electrophoresis matrix and into the recovery well. According to the method, the first and second electrophoresis steps are effective to substantially reduce the concentration of contaminants relative to the concentration of desired nucleic acid in the nucleic acid sample, thereby producing a purified nucleic acid. In the method, the loading and recovery wells may be the same or different, and the electric fields may be DC or alternating. Also disclosed is a preparative electrophoresis method employing an alternating electrical field.
摘要:
In order to reduce the drawbacks, encountered in microwave electronic tubes, resulting from the presence of electrons reflected from the collector of these tubes towards the tube input, the invention provides for the collectors of these tubes to take the form of hollow bodies whose at least part of the internal volume exhibits an axis of symmetry not coinciding with the axis of the beam. This arrangement reduces the number of electrons liable to return towards the tube input and produces a spread in their phases. Application is made to klystrons.
摘要:
Calibration phantom and method for measuring and correcting geometric distortions in an image of a body part of a patient Calibration phantom (5) for a medical imaging system, comprising a plurality of separate detection elements (20) arranged in a determined pattern, each detection element (20) containing a product that is visible by the medical imaging system.
摘要:
Process for determining the configuration or configurations [treatment time (TT.sub.i)/diameter (.phi..sub.i,f) of each collimator] of a helmet for stereotactic radiosurgery, to which can be fitted an plurality of collimators focused on an irradiation isocenter, consisting in automatically optimizing, through iterative dose calculation, the dose (D.sub.p) received at predetermined optimization points (M.sub.p), by modifying, in the course of the successive iterations, the treatment time (TT.sub.i) of at least one shot (i) and the diameter (.phi..sub.i,f) of at least one collimator (C.sub.f) of at least one shot (i), and by calculating, at each iteration, an objective function (OF) having as variables the differences between the calculated dose (D.sub.p) and the expected dose (ED.sub.p) for each point of optimization (M.sub.p), iterative calculation of the doses being carried out automatically until the objective function (OF) satisfies a predetermined optimization criterion.
摘要:
A liner for a deflection yoke assembly for a CRT includes four substantially equally spaced inclined semicircular channel-like mounting studs, arranged about the circumference of a band-like ring about the front of the liner. Threaded sleeves are push mounted upon and ultrasonically welded to an associated mounting stud. Hollow alignment bolts are screwed into each threaded sleeve, and adjustably positioned relative to the cone of a CRT for aligning the yoke to its associated CRT.
摘要:
An electrophoretic method for purifying a nucleic acid sample is disclosed. According to the method, the electrophoresis is effective to substantially reduce the concentration of contaminants relative to the concentration of desired nucleic acid in the nucleic acid sample, thereby producing a purified nucleic acid. In the method, the loading and recovery wells may be the same or different, and the electric fields may be DC or alternating.